MSH3 and breast cancer: No association between homozygous deletion of GSTT1 and response rate in HNSCC,4 but radiosensitivity associated with MSH3 Ala allele in breast cancer patients,5 was previously described during treatment using CDDP-based chemotherapy and RT.